{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:48:51Z","timestamp":1792158531522,"version":"4.4.0"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,27]]},"DOI":"10.1097\/tp.0b013e31824db9da","type":"journal-article","created":{"date-parts":[[2012,3,29]],"date-time":"2012-03-29T05:20:07Z","timestamp":1332998407000},"page":"101-109","source":"Crossref","is-referenced-by-count":86,"title":["Anti-Inflammatory and Immunomodulatory Properties of Azithromycin Involved in Treatment and Prevention of Chronic Lung Allograft Rejection"],"prefix":"10.1097","volume":"94","author":[{"given":"Robin","family":"Vos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart M.","family":"Vanaudenaerde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn E.","family":"Verleden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ruttens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemie","family":"Vaneylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk E.","family":"Van Raemdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven J.","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert M.","family":"Verleden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1053-2498(02)00398-4","article-title":". Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria.","volume":"21","author":"Estenne","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2567.2010.03246.x","article-title":". Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies.","volume":"130","author":"Hagedorn","year":"2010","journal-title":"Immunology"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1053-2498(01)00360-6","article-title":". Risk factors for bronchiolitis obliterans: A systematic review of recent publications.","volume":"21","author":"Sharples","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R4-1-20210129","first-page":"1037","article-title":"Geudens N, et al..","volume":"31","author":"Vos","year":"2008","journal-title":"Pseudomonal airway colonisation: Risk factor for bronchiolitis obliterans syndrome after lung transplantation Eur Respir J"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/thx.2010.155192","article-title":". The impact of traffic air pollution on chronic rejection and mortality after lung transplantation.","volume":"66","author":"Nawrot","year":"2011","journal-title":"Thorax"},{"key":"R6-1-20210129","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1183\/09031936.00064807","article-title":". Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection.","volume":"31","author":"Blondeau","year":"2008","journal-title":"Eur Respir J"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1378\/chest.114.5.1411","article-title":". Bronchiolitis obliterans after lung transplantation: A review.","volume":"114","author":"Boehler","year":"1998","journal-title":"Chest"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1600-6143.2009.02953.x","article-title":"McIlroy El, Gorowiec MR, et al.. Inflammation and epithelial to mesenchymal transition in lung transplant recipients: Role in dysregulated epithelial wound repair.","volume":"10","author":"Borthwick","year":"2010","journal-title":"Am J Transplant"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/j.1600-6143.2008.02321.x","article-title":". The role of the IL23IL17 axis in bronchiolitis obliterans syndrome after lung transplantation.","volume":"8","author":"Vanaudenaerde","year":"2008","journal-title":"Am J Transplant"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.4049\/jimmunol.157.9.4194","article-title":"3rd, Martinez FJ, et al.. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: Role of IL-8.","volume":"157","author":"DiGiovine","year":"1996","journal-title":"J Immunol"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":". Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0924-8579(01)00401-0","article-title":"Macrolides: Structures and microbial targets.","volume":"18","author":"Retsema","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/0924-8579(93)90039-8","article-title":"Therapeutic possibilities for diffuse panbronchiolitis.","volume":"3","author":"Kobayashi","year":"1993","journal-title":"Int J Antimicrob Agents"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":". Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: A randomized controlled trial.","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","article-title":". Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis.","volume":"102","author":"Anwar","year":"2008","journal-title":"Respir Med"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1600-6143.2007.01771.x","article-title":". Transient airway colonization is associated with airway inflammation after lung transplantation.","volume":"7","author":"Vos","year":"2007","journal-title":"Am J Transplant"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1183\/09031936.00095809","article-title":"Azithromycin induces anti-viral responses in bronchial epithelial cells.","volume":"36","author":"Gielen","year":"2010","journal-title":"Eur Respir J"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1399-3062.2010.00509.x","article-title":". Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients.","volume":"12","author":"Weinberg","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pupt.2009.04.004","article-title":". A low concentration of azithromycin inhibits the mRNA expression of N-acyl homoserine lactone synthesis enzymes, upstream of lasI or rhlI, in Pseudomonas aeruginosa.","volume":"22","author":"Kai","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/AAC.01011-06","article-title":". Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(--) mice.","volume":"51","author":"Hoffmann","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1128\/AAC.00511-08","article-title":". Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.","volume":"52","author":"Sugimura","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1128\/AAC.44.10.2869-2872.2000","article-title":". Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis.","volume":"44","author":"Kawamura-Sato","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-1-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1165\/rcmb.2008-0357OC","article-title":". Azithromycin maintains airway epithelial integrity during Pseudomonas aeruginosa infection.","volume":"42","author":"Halldorsson","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R24-1-20210129","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.48.9.3457-3461.2004","article-title":". Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells.","volume":"48","author":"Imamura","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.healun.2008.07.026","article-title":". Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells.","volume":"27","author":"Murphy","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R26-1-20210129","doi-asserted-by":"crossref","first-page":"e5806","DOI":"10.1371\/journal.pone.0005806","article-title":". Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia.","volume":"4","author":"Ribeiro","year":"2009","journal-title":"PLoS One"},{"key":"R27-1-20210129","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00204-008-0388-5","article-title":". Effects of macrolides on proinflammatory epitopes on endothelial cells in vitro.","volume":"83","author":"Millrose","year":"2009","journal-title":"Arch Toxicol"},{"key":"R28-1-20210129","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1183\/09031936.95.08091451","article-title":". Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells.","volume":"8","author":"Khair","year":"1995","journal-title":"Eur Respir J"},{"key":"R29-1-20210129","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/rmed.1999.0781","article-title":". Erythromycin inhibits beta2-integrins (CD11bCD18) expression, interleukin-8 release and intracellular oxidative metabolism in neutrophils.","volume":"94","author":"Lin","year":"2000","journal-title":"Respir Med"},{"key":"R30-1-20210129","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1600-6143.2006.01586.x","article-title":". Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells.","volume":"7","author":"Vanaudenaerde","year":"2007","journal-title":"Am J Transplant"},{"key":"R32-1-20210129","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejphar.2006.09.041","article-title":". Azithromycin has a direct relaxant effect on precontracted airway smooth muscle.","volume":"553","author":"Daenas","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R33-1-20210129","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1183\/09031936.00089407","article-title":". Azithromycin has an antiproliferative and autophagic effect on airway smooth muscle cells.","volume":"34","author":"Stamatiou","year":"2009","journal-title":"Eur Respir J"},{"key":"R34-1-20210129","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/BF01975835","article-title":"Phagocyte uptake and transport of azithromycin.","volume":"10","author":"McDonald","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R35-1-20210129","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1165\/rcmb.2008-0155OC","article-title":". Azithromycin reduces exaggerated cytokine production by M1 alveolar macrophages in cystic fibrosis.","volume":"41","author":"Meyer","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R36-1-20210129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.intimp.2010.12.010","article-title":". Azithromycin inhibits macrophage interleukin-1 production through inhibition of AP-1 in lipopolysaccharide-induced murine pulmonary neutrophilia.","volume":"11","author":"Bosnar","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"R37-1-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1164\/rccm.200711-1666OC","article-title":". Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease.","volume":"178","author":"Hodge","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R38-1-20210129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7150\/ijbs.5.667","article-title":". Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-gamma stimulated macrophages.","volume":"5","author":"Yamauchi","year":"2009","journal-title":"Int J Biol Sci"},{"key":"R39-1-20210129","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/jac\/dkn007","article-title":". Azithromycin alters macrophage phenotype.","volume":"61","author":"Murphy","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R40-1-20210129","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.ftd.0000195617.69721.a5","article-title":"Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis.","volume":"28","author":"Wilms","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R41-1-20210129","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1128\/AAC.43.10.2457","article-title":". The new ketolide HMR3647 accumulates in the azurophil granules of human polymorphonuclear cells.","volume":"43","author":"Miossec-Bartoli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"R42-1-20210129","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2174\/1381612043383430","article-title":"Immunomodulatory effects of macrolides in the lung: Lessons from in-vitro and in-vivo models.","volume":"10","author":"Tsai","year":"2004","journal-title":"Curr Pharm Des"},{"key":"R43-1-20210129","first-page":"5S","article-title":"Clinical implications of the immunomodulatory effects of macrolides.","volume":"117","author":"Tamaoki","year":"2004","journal-title":"Am J Med"},{"key":"R44-1-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0952-3278(03)00089-9","article-title":". Macrolide antibiotics inhibit prostaglandin E2 synthesis and mRNA expression of prostaglandin synthetic enzymes in human leukocytes.","volume":"69","author":"Miyazaki","year":"2003","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R45-1-20210129","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.intimp.2004.05.011","article-title":". Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via downregulation of Bcl-xL.","volume":"4","author":"Mizunoe","year":"2004","journal-title":"Int Immunopharmacol"},{"key":"R46-1-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0924-8579(98)00091-0","article-title":". Effect of clarithromycin and azithromycin on production of cytokines by human monocytes.","volume":"11","author":"Khan","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"R47-1-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1189\/jlb.1210655","article-title":". Azithromycin drives in vitro GM-CSFIL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties.","volume":"91","author":"Stupin Polancec","year":"2012","journal-title":"J Leukoc Biol"},{"key":"R48-1-20210129","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2249.2007.03299.x","article-title":". Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells.","volume":"147","author":"Sugiyama","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"R49-1-20210129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2249.2011.04480.x","article-title":". The effect of azithromycin on the maturation and function of murine bone marrow-derived dendritic cells.","volume":"166","author":"Iwamoto","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"R50-1-20210129","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1432-2277.2008.00670.x","article-title":". Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injury.","volume":"21","author":"Geudens","year":"2008","journal-title":"Transpl Int"},{"key":"R51-1-20210129","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/01902140902918755","article-title":". The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.","volume":"35","author":"Remund","year":"2009","journal-title":"Exp Lung Res"},{"key":"R52-1-20210129","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.trim.2011.06.006","article-title":". Azithromycin decreases MMP-9 expression in the airways of lung transplant recipients.","volume":"25","author":"Verleden","year":"2011","journal-title":"Transpl Immunol"},{"key":"R53-1-20210129","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2174\/092986708783885228","article-title":"Lung transplantation: The role of azithromycin in the management of patients with bronchiolitis obliterans syndrome.","volume":"15","author":"Fietta","year":"2008","journal-title":"Curr Med Chem"},{"key":"R54-1-20210129","doi-asserted-by":"crossref","first-page":"E381","DOI":"10.1111\/j.1399-0012.2011.01435.x","article-title":". Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection.","volume":"25","author":"Frederica","year":"2011","journal-title":"Clin Transplant"},{"key":"R55-1-20210129","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.intimp.2007.07.031","article-title":". The serum amyloid A response to sterile silver nitrate in mice and its inhibition by dexamethasone and macrolide antibiotics.","volume":"7","author":"Glojnaric","year":"2007","journal-title":"Int Immunopharmacol"},{"key":"R56-1-20210129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","article-title":". Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomised trial.","volume":"57","author":"Wolter","year":"2002","journal-title":"Thorax"},{"key":"R57-1-20210129","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/bdd.767","article-title":"Distribution characteristics of clarithromycin and azithromycin, macrolide anti-microbial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.","volume":"32","author":"Togami","year":"2011","journal-title":"Biopharm Drug Dispos"},{"key":"R58-1-20210129","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.idc.2009.06.013","article-title":"Macrolides, ketolides, and glycylcyclines: Azithromycin, clarithromycin, telithromycin, tigecycline.","volume":"23","author":"Zuckerman","year":"2009","journal-title":"Infect Dis Clin North Am"},{"key":"R59-1-20210129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1378\/chest.08-3056","article-title":". Azithromycin attenuates airway inflammation in a noninfectious mouse model of allergic asthma.","volume":"136","author":"Beigelman","year":"2009","journal-title":"Chest"},{"key":"R60-1-20210129","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/COPD.S681","article-title":"Role of macrolide therapy in chronic obstructive pulmonary disease.","volume":"3","author":"Martinez","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R61-1-20210129","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1432-2277.2002.tb00093.x","article-title":". The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation.","volume":"15","author":"Sarahrudi","year":"2002","journal-title":"Transpl Int"},{"key":"R62-1-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1164\/rccm.200212-1424BC","article-title":". Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: Results of a pilot study.","volume":"168","author":"Gerhardt","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R63-1-20210129","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.TP.0000122412.80864.43","article-title":"Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation.","volume":"77","author":"Verleden","year":"2004","journal-title":"Transplantation"},{"key":"R64-1-20210129","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1164\/rccm.200411-1537OC","article-title":". Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.","volume":"172","author":"Yates","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R65-1-20210129","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.healun.2004.08.006","article-title":". Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.","volume":"24","author":"Shitrit","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R66-1-20210129","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1164\/rccm.200601-071OC","article-title":". Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.","volume":"174","author":"Verleden","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R67-1-20210129","first-page":"1358","article-title":"Ottevaere A, et al..","volume":"29","author":"Vos","year":"2010","journal-title":"Long-term azithromycin for bronchiolitis obliterans syndrome: Divide and conquer J Heart Lung Transplant"},{"key":"R68-1-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1155\/2008\/158681","article-title":". Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients.","volume":"15","author":"Porhownik","year":"2008","journal-title":"Can Respir J"},{"key":"R69-1-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000295981.84633.bc","article-title":". Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.","volume":"85","author":"Gottlieb","year":"2008","journal-title":"Transplantation"},{"key":"R70-1-20210129","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.healun.2009.12.003","article-title":". Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.","volume":"29","author":"Jain","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R71-1-20210129","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/TP.0b013e3181a492b2","article-title":"Long-term clarithromycin therapy in the management of lung transplant recipients.","volume":"87","author":"Benden","year":"2009","journal-title":"Transplantation"},{"key":"R72-1-20210129","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2004.06.025","article-title":". Effect of azithromycin on bronchiectasis and pulmonary function in a heart-lung transplant patient with severe chronic allograft dysfunction: A case report.","volume":"24","author":"Verleden","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R73-1-20210129","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1007\/s00330-011-2224-1","article-title":". Thin-section Computed Tomography findings before and after azithromycin treatment of neutrophilic reversible lung allograft dysfunction.","volume":"21","author":"de Jongh","year":"2011","journal-title":"Eur Radiol"},{"key":"R74-1-20210129","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.healun.2010.12.008","article-title":". Airway protein diversity in bronchiolitis obliterans syndrome after lung transplantation.","volume":"30","author":"Verleden","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R75-1-20210129","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s10620-009-0725-4","article-title":". Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients.","volume":"54","author":"Mertens","year":"2009","journal-title":"Dig Dis Sci"},{"key":"R76-1-20210129","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.2506011","article-title":"Azithromycin: A plea for multicenter randomized studies in lung transplantation.","volume":"172","author":"Williams","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R77-1-20210129","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.00134307","article-title":". A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.","volume":"32","author":"Vanaudenaerde","year":"2008","journal-title":"Eur Respir J"},{"key":"R78-1-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/187152808786848414","article-title":". Macrolide therapy targets a specific phenotype in respiratory medicine: From clinical experience to basic science and back.","volume":"7","author":"Vanaudenaerde","year":"2008","journal-title":"Inflamm Allergy Drug Targets"},{"key":"R79-1-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1183\/09031936.00068310","article-title":". A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.","volume":"37","author":"Vos","year":"2011","journal-title":"Eur Respir J"},{"key":"R80-1-20210129","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/clinids\/24.5.958","article-title":". Relationship of adverse events to serum drug levels in patients receiving high-dose azithromycin for mycobacterial lung disease.","volume":"24","author":"Brown","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R81-1-20210129","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320512","article-title":". Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease.","volume":"32","author":"Griffith","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R82-1-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0924-8579(01)00397-1","article-title":"Comparative safety of the different macrolide.","volume":"18","author":"Rubinstein","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"R83-1-20210129","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2125.2000.00261.x","article-title":"Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: An update focused on clarithromycin, azithromycin and dirithromycin.","volume":"50","author":"Westphal","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"R84-1-20210129","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1540-8159.2000.tb00976.x","article-title":"Potentially fatal interaction between azithromycin and disopyramide.","volume":"23","author":"Granowitz","year":"2000","journal-title":"Pacing Clin Electrophysiol"},{"key":"R85-1-20210129","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/jam.2006.19.54","article-title":". Inhaled azithromycin therapy.","volume":"19","author":"Hickey","year":"2006","journal-title":"J Aerosol Med"},{"key":"R86-1-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2010.05.043","article-title":". High azithromycin loading powders for inhalation and their in vivo evaluation in rats.","volume":"395","author":"Zhang","year":"2010","journal-title":"Int J Pharm"},{"key":"R87-1-20210129","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":". Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: A randomised, double-blind, placebo-controlled study.","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"R88-1-20210129","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/AAC.41.10.2251","article-title":". mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.","volume":"41","author":"Tait-Kamradt","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"R89-1-20210129","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.patbio.2009.07.018","article-title":". 10th Survey of antimicrobial resistance in noninvasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2007-2008.","volume":"58","author":"Vanhoof","year":"2010","journal-title":"Pathol Biol"},{"key":"R90-1-20210129","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.inf.0000247109.44249.ac","article-title":". Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: Long-term outcomes related to macrolide resistance and pulmonary function.","volume":"26","author":"Tramper-Stranders","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R91-1-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/dkl014","article-title":". Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.","volume":"57","author":"Phaff","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R92-1-20210129","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1128\/AAC.49.9.3858-3867.2005","article-title":". Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms.","volume":"49","author":"Gillis","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R93-1-20210129","first-page":"3611","article-title":"Macrolides: A treatment alternative for bronchiolitis obliterans organizing pneumonia C","volume":"128","author":"Stover","year":"2005","journal-title":"hest"},{"key":"R94-1-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajim.20196","article-title":". World Trade Center dyspnea: Bronchiolitis obliterans with functional improvement: A case report.","volume":"48","author":"Mann","year":"2005","journal-title":"Am J Ind Med"},{"key":"R95-1-20210129","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/09031936.05.00020804","article-title":". Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: A preliminary study.","volume":"25","author":"Khalid","year":"2005","journal-title":"Eur Respir J"},{"key":"R96-1-20210129","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3109\/01902148.2010.492895","article-title":". Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.","volume":"36","author":"Wuyts","year":"2010","journal-title":"Exp Lung Res"},{"key":"R97-1-20210129","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.transproceed.2011.02.021","article-title":". Neutrophilic reversible airways dysfunction after liver transplantation: A case report.","volume":"43","author":"Verleden","year":"2011","journal-title":"Transplant Proc"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201207270-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:38:21Z","timestamp":1786048701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201207270-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,27]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e31824db9da","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7,27]]}}}